Amphastar Pharmaceuticals (AMPH) Tax Provisions (2013 - 2026)

Amphastar Pharmaceuticals' Tax Provisions history runs 14 years deep, the most recent figure standing at $3.6 million for Q1 2026.

• In Q1 2026, Tax Provisions fell 34.88% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $23.6 million (down 24.22% YoY), while the FY2025 annual figure was $25.5 million, down 13.96% from the prior year.
• Tax Provisions was $3.6 million for Q1 2026 at Amphastar Pharmaceuticals, down from $7.5 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $14.0 million in Q3 2023 to a low of $3.6 million in Q1 2026.
• Historically, Tax Provisions has averaged $6.7 million across 5 years, with a median of $6.4 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions surged 252.99% in 2022, then slumped 48.28% in 2024.
• A 5-year view of Tax Provisions shows it stood at $7.3 million in 2022, then sank by 35.9% to $4.7 million in 2023, then grew by 28.35% to $6.0 million in 2024, then increased by 24.79% to $7.5 million in 2025, then tumbled by 51.48% to $3.6 million in 2026.
• The last three Tax Provisions figures came in at $3.6 million (Q1 2026), $7.5 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.